They observed frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6, and WT1 genes in both DCIS and adjacent invasive ductal adenocarcinoma lesions. This evidence concerns the gene CDH13 and ductal breast carcinoma in situ.